We thus injected Met-1 TripZ-EV and Met-1 TripZ-200c cells orthotopically into syngeneic FVB/NJ mice and initiated treatment with Dox, in the diet/chow, when the average tumor volume reached 50 mm3. The gene discussed is MET; the disease is neoplasm.